655
Views
30
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Hepatitis B virus reactivation in patients with multiple myeloma receiving bortezomib-containing regimens followed by autologous stem cell transplant

, , , , &
Pages 1710-1717 | Received 06 Apr 2014, Accepted 29 Jun 2014, Published online: 14 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Shang-Chin Huang, Hung-Chih Yang & Jia-Horng Kao. (2020) Hepatitis B reactivation: diagnosis and management. Expert Review of Gastroenterology & Hepatology 14:7, pages 565-578.
Read now
Mauro Viganò, Giuseppe Serra, Giovanni Casella, Glenda Grossi & Pietro Lampertico. (2016) Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders. Expert Opinion on Biological Therapy 16:7, pages 917-926.
Read now

Articles from other publishers (27)

Jun Ho Yi, Jung Lim Lee, Yoo Jin Lee, Hye Jin Kang, Young Hoon Park, Young Jin Yuh, Sung-Nam Lim, Hyo Jung Kim, Sung-Hoon Jung, Je-Jung Lee, Hee Jeong Cho, Joon Ho Moon, Ho-Young Yhim & Kihyun Kim. (2023) Outcome of Multiple Myeloma Patients With Hepatitis B Surface Antigen: Korean Multiple Myeloma Working Party 2103 Study. Clinical Lymphoma Myeloma and Leukemia.
Crossref
Joyce Wing Yan Mak, Alvin Wing Hin Law, Kimmy Wan Tung Law, Rita Ho, Carmen Ka Man Cheung & Man Fai Law. (2023) Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era. World Journal of Gastroenterology 29:33, pages 4942-4961.
Crossref
Shohei Mizuno, Akiyoshi Takami, Hiroyuki Takamatsu, Ichiro Hanamura, Yutaka Shimazu, Akira Hangaishi, Nobuhiro Tsukada, Shinichi Kako, Taku Kikuchi, Shuichi Ota, Hiroaki Shimizu, Shinsuke Iida, Satoshi Yoshioka, Masashi Sawa, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta & Koji Kawamura. (2022) Autologous hematopoietic cell transplantation for myeloma patients with hepatitis B virus or hepatitis C virus in the era of novel agents. Bone Marrow Transplantation 57:5, pages 846-848.
Crossref
George Lau, Ming-Lung Yu, Grace Wong, Alexander Thompson, Hasmik Ghazinian, Jin-Lin Hou, Teerha Piratvisuth, Ji-Dong Jia, Masashi Mizokami, Gregory Cheng, Guo-Feng Chen, Zhen-Wen Liu, Oidov Baatarkhuu, Ann Lii Cheng, Woon Leung Ng, Patrick Lau, Tony Mok, Jer-Ming Chang, Saeed Hamid, A. Kadir Dokmeci, Rino A. Gani, Diana A. Payawal, Pierce Chow, Joong-Won Park, Simone I. Strasser, Rosmawaiti Mohamed, Khin Maung Win, Tanwandee Tawesak, Shiv Kumar Sarin & Masao Omata. (2021) APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy. Hepatology International 15:5, pages 1031-1048.
Crossref
Chih-An Shih & Wen-Chi Chen. (2021) Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy. World Journal of Clinical Cases 9:21, pages 5769-5781.
Crossref
Giuseppe Indolfi, Mona Abdel-Hady, Sanjay Bansal, Dominique Debray, Françoise Smets, Piotr Czubkowski, Wendy van der Woerd, Marianne Samyn, Jörg Jahnel, Girish Gupte, Aglaia Zellos, Yael Mozer-Glassberg, Henkjan J. Verkade, Etienne Sokal & Björn Fischler. (2020) Management of Hepatitis B Virus Infection and Prevention of Hepatitis B Virus Reactivation in Children With Acquired Immunodeficiencies or Undergoing Immune Suppressive, Cytotoxic, or Biological Modifier Therapies. Journal of Pediatric Gastroenterology & Nutrition 70:4, pages 527-538.
Crossref
Xuzhao Zhang, Yun Liang, Xian Li, Weiqin Wang, Jiefeng Tong & Yang Xu. (2020) Clearance of HBsAg in a patient with familial multiple myeloma after a bortezomib-based regimen combined with anti-HBV drug. Medicine 99:40, pages e22642.
Crossref
Danielle J. Smalls, Reagan E. Kiger, LeAnn B. Norris, Charles L. Bennett & Bryan L. Love. (2019) Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39:12, pages 1190-1203.
Crossref
Yutaka Tsukune, Makoto Sasaki & Norio Komatsu. (2019) Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma. Cancers 11:11, pages 1819.
Crossref
Gentile & Antonelli. (2019) HBV Reactivation in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Narrative Review. Viruses 11:11, pages 1049.
Crossref
Dan Guo, Peipei Xu, Chaoyang Guan, Yong Xu, Yonggong Yang, Jingyan Xu, Rongfu Zhou & Bing Chen. (2019) Hepatitis B virus infection and 1q21 amplification in multiple myeloma. Oncology Letters.
Crossref
Joe Sasadeusz, Andrew Grigg, Peter D. Hughes, Seng Lee Lim, Michaela Lucas, Geoff McColl, Sue Anne McLachlan, Marion G. Peters, Nicholas Shackel, Monica Slavin, Vijaya Sundararajan, Alexander Thompson, Joseph Doyle, James Rickard, Peter De Cruz, Robert G. Gish & Kumar Visvanathan. (2019) Screening and Prophylaxis to Prevent Hepatitis B Reactivation. Clinics in Liver Disease 23:3, pages 521-534.
Crossref
Joe Sasadeusz, Andrew Grigg, Peter D. Hughes, Seng Lee Lim, Michaela Lucas, Geoff McColl, Sue Anne McLachlan, Marion G. Peters, Nicholas Shackel, Monica Slavin, Vijaya Sundararajan, Alexander Thompson, Joseph Doyle, James Rickard, Peter De Cruz, Robert G. Gish & Kumar Visvanathan. (2019) Screening and Prophylaxis to Prevent Hepatitis B Reactivation. Clinics in Liver Disease 23:3, pages 511-519.
Crossref
Caterina Sagnelli, Mariantonietta Pisaturo, Federica Calò, Salvatore Martini, Evangelista Sagnelli & Nicola Coppola. (2019) Reactivation of hepatitis B virus infection in patients with hemo-lymphoproliferative diseases, and its prevention. World Journal of Gastroenterology 25:26, pages 3299-3312.
Crossref
Moritz Schmidt, Vanessa Altdörfer, Sarah Schnitte, Alexander Rolf Fuchs, Korbinian Nepomuk Kropp, Stefanie Maurer, Martin Rudolf Müller, Helmut Rainer Salih, Susanne Malaika Rittig, Frank Grünebach & Daniela Dörfel. (2019) The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells. Neoplasia 21:7, pages 653-664.
Crossref
Corrado Girmenia, Michele Cavo, Massimo Offidani, Francesco Scaglione, Alessandro Corso, Francesco Di Raimondo, Pellegrino Musto, Maria Teresa Petrucci & Giovanni Barosi. (2019) Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations. Blood Reviews 34, pages 84-94.
Crossref
Yutaka Tsukune, Makoto Sasaki, Takeshi Odajima, Kazutaka Sunami, Tomomi Takei, Yukiyoshi Moriuchi, Masaki Iino, Atsushi Isoda, Aya Nakaya, Tsuyoshi Muta, Takaaki Miyake, Koji Miyazaki, Takayuki Shimizu, Kei Nakajima, Aiko Igarashi, Koji Nagafuji, Taro Kurihara, Tomonori Aoyama, Hiroki Sugimori & Norio Komatsu. (2017) Incidence and risk factors of hepatitis B virus reactivation in patients with multiple myeloma in an era with novel agents: a nationwide retrospective study in Japan. Blood Cancer Journal 7:12.
Crossref
Rohit Loomba & T. Jake Liang. (2017) Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions. Gastroenterology 152:6, pages 1297-1309.
Crossref
Ankur Varma, Laura Biritxinaga, Rima M. Saliba, Maximilian Stich, Sarah Francesca Jauch, Aimaz Afrough, Medhavi Honhar, Uday R. Popat, Mehnaz A. Shafi, Nina Shah, Qaiser Bashir, Yvonne Dinh, Chitra Hosing, Richard E. Champlin & Muzaffar H. Qazilbash. (2017) Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma. Biology of Blood and Marrow Transplantation 23:4, pages 581-587.
Crossref
Majed M. Almaghrabi, Kyle J. Fortinsky & David Wong. (2017) Severe Acute Hepatitis B in HBV-Vaccinated Partner of a Patient with Multiple Myeloma Treated with Cyclophosphamide, Bortezomib, and Dexamethasone and Autologous Stem Cell Transplant. Case Reports in Hepatology 2017, pages 1-4.
Crossref
Yutaka Tsukune, Makoto Sasaki, Takeshi Odajima, Atsushi Isoda, Morio Matsumoto, Michiaki Koike, Hideto Tamura, Keiichi Moriya, Shigeki Ito, Maki Asahi, Yoichi Imai, Junji Tanaka, Hiroshi Handa, Hiromi Koiso, Sakae Tanosaki, Jian Hua, Masao Hagihara, Yuriko Yahata, Satoko Suzuki, Sumio Watanabe, Hiroki Sugimori & Norio Komatsu. (2016) Incidence and clinical background of hepatitis B virus reactivation in multiple myeloma in novel agents? era. Annals of Hematology 95:9, pages 1465-1472.
Crossref
Venessa Pattullo. (2016) Prevention of Hepatitis B reactivation in the setting of immunosuppression. Clinical and Molecular Hepatology 22:2, pages 219-237.
Crossref
Vincent Mallet, Florian van Bömmel, Christopher Doerig, Sven Pischke, Olivier Hermine, Anna Locasciulli, Catherine Cordonnier, Thomas Berg, Darius Moradpour, Heiner Wedemeyer & Per Ljungman. (2016) Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5). The Lancet Infectious Diseases 16:5, pages 606-617.
Crossref
Eric Chow, Zainab Shahid, Elton T. SmithJr.Jr., Michal Kamionek & Saad Z. Usmani. (2016) Successful Treatment of Hepatitis C Infection While Receiving Concurrent Chemotherapy for AL Amyloidosis. Clinical Lymphoma Myeloma and Leukemia 16:4, pages 237-239.
Crossref
Man Fai Law, Rita Ho, Carmen K M Cheung, Lydia H P Tam, Karen Ma, Kent C Y So, Bonaventure Ip, Jacqueline So, Jennifer Lai, Joyce Ng & Tommy H C Tam. (2016) Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy. World Journal of Gastroenterology 22:28, pages 6484.
Crossref
Colin Phipps, Yunxin Chen & Daryl Tan. (2016) Lymphoproliferative Disease and Hepatitis B Reactivation: Challenges in the Era of Rapidly Evolving Targeted Therapy. Clinical Lymphoma Myeloma and Leukemia 16:1, pages 5-11.
Crossref
Venessa Pattullo. (2015) Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure. World Journal of Hepatology 7:7, pages 954.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.